Cabot Corporation
CBT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.42 | 1.06 | 10.09 | -0.40 |
| FCF Yield | 3.74% | 5.36% | -0.58% | 0.95% |
| EV / EBITDA | 27.80 | 23.42 | 26.76 | 30.02 |
| Quality | ||||
| ROIC | 1.97% | 3.77% | 3.49% | 3.70% |
| Gross Margin | 24.81% | 26.44% | 25.75% | 24.61% |
| Cash Conversion Ratio | 5.09 | 2.47 | 0.70 | 1.19 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.88% | -2.20% | -2.83% | -2.62% |
| Free Cash Flow Growth | -27.91% | 926.92% | -155.32% | -58.04% |
| Safety | ||||
| Net Debt / EBITDA | 5.30 | 4.58 | 5.17 | 5.10 |
| Interest Coverage | 6.85 | 8.79 | 8.53 | 8.61 |
| Efficiency | ||||
| Inventory Turnover | 1.27 | 1.28 | 1.28 | 1.34 |
| Cash Conversion Cycle | 60.32 | 58.57 | 66.40 | 55.93 |